Ratings Laurentian Bank of Canada OTC Markets

Equities

LRCDF

CA51925D1069

Market Closed - OTC Markets Other stock markets 11:06:16 2024-06-25 EDT			5-day change	1st Jan Change
19.46 ^USD	+1.60%		+1.63%	-7.19%

06-12	With acquisition, Canada's National Bank expands west and analysts applaud growth potential	RE
06-06	Laurentian Bank Brief: That being the first business day following the conversion date of June 15, 2024, into Non-Cumulative Class A Preferred Shares, Series 14 of the Bank	MT

Strengths

The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company benefits from high valuations in earnings multiples.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Over the past twelve months, analysts' opinions have been revised negatively.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Banks

	1st Jan change	Capi.	ESG Refinitiv
LAURENTIAN BANK OF CANADA	-7.19%	849M	-
JPMORGAN CHASE & CO.	+16.44%	569B	C+
BANK OF AMERICA CORPORATION	+16.96%	308B	C+
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED	+20.68%	259B	C+
CHINA CONSTRUCTION BANK CORPORATION	+24.95%	188B	B-
BANK OF CHINA LIMITED	+28.52%	172B	B-
HSBC HOLDINGS PLC	+8.10%	160B	C+
HDFC BANK LIMITED	-0.80%	156B	B-
ROYAL BANK OF CANADA	+8.39%	150B	B-
COMMONWEALTH BANK OF AUSTRALIA	+13.52%	143B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes